0001348076-17-000002.txt : 20170112 0001348076-17-000002.hdr.sgml : 20170112 20170112154508 ACCESSION NUMBER: 0001348076-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170112 DATE AS OF CHANGE: 20170112 EFFECTIVENESS DATE: 20170112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cavion, Inc. CENTRAL INDEX KEY: 0001348076 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-278301 FILM NUMBER: 17525104 BUSINESS ADDRESS: STREET 1: 600 EAST WATER STREET, SUITE E CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: (434) 989-6299 MAIL ADDRESS: STREET 1: 600 EAST WATER STREET, SUITE E CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 FORMER COMPANY: FORMER CONFORMED NAME: Cavion LLC DATE OF NAME CHANGE: 20160111 FORMER COMPANY: FORMER CONFORMED NAME: TAU Therapeutics LLC DATE OF NAME CHANGE: 20130115 FORMER COMPANY: FORMER CONFORMED NAME: Tau Therapeutics LLC DATE OF NAME CHANGE: 20051227 D 1 primary_doc.xml X0707 D LIVE 0001348076 Cavion, Inc. 600 EAST WATER STREET, SUITE E CHARLOTTESVILLE VA VIRGINIA 22902 (434) 989-6299 DELAWARE Cavion LLC TAU Therapeutics LLC Tau Therapeutics LLC Corporation true 2016 Andrew J Krouse c/o Cavion, Inc. 600 East Water Street, Suite E Charlottesville VA VIRGINIA 22902 Executive Officer Director Anne Heldreth c/o Cavion, Inc. 600 East Water Street, Suite E Charlottesville VA VIRGINIA 22902 Executive Officer Henry Skinner c/o Cavion, Inc. 600 East Water Street, Suite E Charlottesville VA VIRGINIA 22902 Director Steve Hall c/o Cavion, Inc. 600 East Water Street, Suite E Charlottesville VA VIRGINIA 22902 Director Sergei Petukhov c/o Cavion, Inc. 600 East Water Street, Suite E Charlottesville VA VIRGINIA 22902 Director David E Gibson c/o Cavion, Inc. 600 East Water Street, Suite E Charlottesville VA VIRGINIA 22902 Director Biotechnology Decline to Disclose 06b false 2016-12-28 false true true true Offer and sale of shares of preferred stock and the underlying shares of common stock issuable upon conversion thereof; conversion of notes and the underlying shares of common stock issuable upon conversion thereof. false 0 31512867 22312867 9200000 false 19 0 0 0 false Cavion, Inc. /s/ Andrew J. Krouse Andrew J. Krouse Chief Executive Officer 2017-01-12